
Pharmaceuticals · Listed on BSE , NSE · 21 Nov 2025 - 25 Nov 2025
Sudeep Pharma Limited, founded in 1989, is one of the leading manufacturers of excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries. They aim to support the global healthcare ecosystem by serving their product to over 100 countries and supplying more than 200 products. To support innovation in their work, they use their own in-house technologies for encapsulation, spray drying, granulation, trituration, liposomal preparations, and mixing.
Their business is basically structured into 2 verticals: 1) Pharmaceutical, food, and nutrition, which includes key mineral salts such as calcium, zinc, iron, potassium, magnesium, sodium, and copper, and 2) Specialty Ingredients includes micronutrient premixes, encapsulated ingredients, granulated minerals, and triturated blends. Moreover, Sudeep Pharma runs six manufacturing facilities with a total production capacity of 50,000 MT.
| Date & Time | GMP (₹) | Est. Listing Price | Est. Gain (%) | Est. Profit / Lot (₹) |
|---|---|---|---|---|
| 28-Nov-2025 08:00 AM | +₹115 | ₹708 | +19.39% | ₹2,875 |
| 26-Nov-2025 06:00 PM | +₹85 | ₹678 | +14.33% | ₹2,125 |
| 24-Nov-2025 06:00 PM | +₹115 | ₹708 | +19.39% | ₹2,875 |
| 21-Nov-2025 06:00 PM | +₹118 | ₹711 | +19.90% | ₹2,950 |
| 19-Nov-2025 06:00 PM | +₹93 | ₹686 | +15.68% | ₹2,325 |
| Category | Subscription (x) | Shares Offered | Shares bid for | Total Amount (₹ Cr) |
|---|---|---|---|---|
| QIB (Ex. Anchor) | 213.08x | 30,18,550 | 64,31,88,450 | ₹38,141.08 Cr |
| NII | 116.23x | 22,63,913 | 26,31,24,475 | ₹15,603.28 Cr |
| bNII > ₹10L | 134.91x | 15,09,276 | 20,36,19,700 | ₹12,074.65 Cr |
| sNII < ₹10L | 78.85x | 7,54,637 | 5,95,04,775 | ₹3,528.63 Cr |
| Retail | 14.59x | 52,82,463 | 7,70,55,000 | ₹4,569.36 Cr |
| Total | 93.08x | 1,05,64,926 | 98,33,67,925 | ₹58,313.72 Cr |
| Period Ended | 30 JUN 2025 | 31 MAR 2025 | 31 MAR 2024 | 31 MAR 2023 |
|---|---|---|---|---|
| Assets | 922.26 | 717.17 | 513.87 | 420.11 |
| Total Income | 130.08 | 511.33 | 465.38 | 438.26 |
| Profit After Tax | 31.27 | 138.69 | 133.15 | 62.32 |
| EBITDA | 48.57 | 199.28 | 187.76 | 98.64 |
| NET Worth | 688.32 | 497.53 | 359.07 | 226.29 |
| Reserves and Surplus | 668.52 | 481.11 | 354.59 | 221.88 |
| Total Borrowing | 135.97 | 135.25 | 75.03 | 82.26 |
Peer comparison data will be updated soon.
Sujit Jaysukh Bhayani, Avani Sujit Bhayani, Shanil Sujit Bhayani, Sujeet Jaysukh Bhayani (HUF), Riva Resources Pvt.Ltd. and Bhayani Family Trust. is the company's promoter of Sudeep Pharma.
| Particular | Pre IPO | Post IPO |
|---|---|---|
| Promoter and Promoter Group | 89.37% | 76.15% |
| Others* | 10.63% | 23.85% |
Join the discussion
Please sign in to leave a comment or reply.